Intelliheart tests in Amcal pharmacies

By Dylan Bushell-Embling
Friday, 13 June, 2008

IM Medical (ASX: IMI) has reached an exclusive agreement with Sigma Pharmaceuticals that will see the Intelliheart cardiac risk assessment tests sold through Sigma's Amcal network.

The Amcal network includes over 700 Amcal, Amcal Max and Guardian pharmacies throughout the country.

The product will initially be rolled out to over 200 pharmacies throughout Victoria in July. Stores in other states will begin stocking the product in the next few months.

Under the agreement Sigma has the right to produce and market other products using the Intelliheart brand name.

Intelliheart is the only widely available diagnostic which tests for both heart rate variability and arterial stiffness.

Related News

Novel antibiotic activates 'suicide' mechanism in superbug

Researchers have discovered a new class of antibiotic that selectively targets Neisseria...

Modifications in the placenta linked to psychiatric disorders

Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders...

ADHD may be linked with an increased risk of dementia

An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd